본문 바로가기
KERD
논문KCI 등재

Bisphosphonate-related osteonecrosis of jaw의 치료에 대한 고찰

Consideration for treatment of bisphosphonate-related osteonecrosis of the jaw

정정권|배정호|백지선|신재명|윤규호|유경하|박재안|박군찬
대한구강악안면외과학회 (Korean Association Of Oral And Maxillofacial Surgeons)|2010.06|대한구강악안면외과학회지 (Journal of the Korean Association of Oral and Maxillofacial Surgeons)|제36권 제3호|pp. 206-210

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

OsteoporosisBisphosphonateOsteonecrosis
주제분류치의학

초록

Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus,consideration of prevention and needs regarding unequivocal treatment regimen have emerged. Recently, several authors emphasized reports on appropriate clinical availability of surgical approach. It serves to concern about guideline for surgical and conservative treatment modalities. So, it is the purpose of this paper to review the current literatures about treatment regimens of BRONJ.

Abstract

Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus,consideration of prevention and needs regarding unequivocal treatment regimen have emerged. Recently, several authors emphasized reports on appropriate clinical availability of surgical approach. It serves to concern about guideline for surgical and conservative treatment modalities. So, it is the purpose of this paper to review the current literatures about treatment regimens of BRONJ.

참고문헌 (33)

  1. Owens G, "An integrated approach: bisphosphonate management for treatment of osteoporosis", Am J Manag Care, 13(11), pp.290~308 (2007)
  2. Marx RE, "Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
  3. Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development", J Oral Maxillofac Surg, 67(5), pp.13~18 (2009)
  4. Ruggiero SL, "Osteonecrosis of the jaws and bisphosphonate therapy", J Dent Res, 86, pp.1013~1021 (2007)
  5. Mavrokokki T, "Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia", J Oral Maxillofac Surg, 65, pp.415~423 (2007)
  6. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
  7. 대한내분비학회, "비스포스포네이트와 관련한 악골(턱뼈) 괴사", 대한내분비학회지, 24(4), pp.227~230 (2009), 대한내분비학회
  8. 오주영, "Bisphosphonate-related osteonecrosis of the jaw의 병리조직학적 소견 및 방사선학적 특징에 대한 임상적 고찰", 대한구강악안면외과학회지, 34(5), pp.550~554 (2008), 대한구강악안면외과학회
  9. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update", J Oral Maxillofac Surg, 67(5), pp.2~12 (2009)
  10. 권용대, "Bisphosphonate, 구강악안면외과 영역의 새로운 위험 요소인가?", 대한악안면성형재건외과학회지, 29(5), pp.456~462 (2007), 대한악안면성형재건외과학회
  11. Siddiqi A, "Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, pp.1~8 (2009)
  12. Hansen T, "Osteonecrosis of the jaws in patients treated with bisphosphonates- histomorphologic analysis in comparison with infected osteonecrosis", J Oral Pathol Med, 35, pp.155~160 (2006)
  13. Migliorati CA, "Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper", J Am Dent Assoc, 136, pp.1658~1668 (2005)
  14. Sawatari Y, "Bisphosphonates and bisphosphonate induced osteonecrosis", Oral Maxillofac Surg Clin North Am, 19, pp.487~498 (2007)
  15. Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a reviews of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
  16. Chaudhry AN, "Osteonecrosis and bisphosphonates in oral and maxillofacial surgery", ral Maxillofac Surg Clin North Am, 19, pp.199~206 (2007)
  17. Marx RE, "Bisphosphonateinduced exposed bone (osteonecrosis", osteopetrosis)of the jaws: risk factors, recognition, prevention, and treatment, 2005, pp.63, 1567~1575
  18. Lazarovici TS, "Bisphosphonate-related osteonecrosis of the jaws: a singlecenter study of 101 patients", J Oral Maxillofac Surg, 67, pp.850~855 (2009)
  19. Thumbigere-Math V, "Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients", J Oral Maxillofac Surg, 67, pp.1904~1913 (2009)
  20. Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 102, pp.433~441 (2006)
  21. Tirelli G, "Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach", Head Neck, 31, pp.1249~1254 (2009)
  22. Stanton DC, "Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases", J Oral Maxillofac Surg, 67, pp.943~950 (2009)
  23. Arce K, "findings in bisphosphonate-related osteonecrosis of jaws", J Oral Maxillofac Surg, 67(5), pp.75~84 (2009)
  24. Wutzl A, "Treatement results of bisphosphonate-related osteonecrosis of the jaws", Head Neck, 30, pp.1224~1230 (2008)
  25. Carlson ER, "The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5), pp.85~95 (2009)
  26. Freiberger JJ, "Utility of hyperbaric oxygen in treatment of bisphosphonate- related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5), pp.96~106 (2009)
  27. Mignogna MD, "Case 2. Osteoenecrosis of the jaws associated with bisphosphonate therapy", J Clin Oncol, 24, pp.1475~1477 (2006)
  28. Magopoulos C, "Vahtsevanos K, Dimitrakopoulos l, Antoniadis K, et al. Osteoenecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals", Am J Otolaryngol, 28, pp.158~163 (2007)
  29. Nastro E, "Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer", Acta Haematol, 117, pp.181~187 (2007)
  30. Black DM, "Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension(FLEX): a randomized trial", JAMA, 296, pp.2927~2938 (2006)
  31. Khosla S, "American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22, pp.1479~1491 (2007)
  32. Assael LA, "Oral bisphosphonates as a cause of bisphosphonaterelated osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies", J Oral Maxillofac Surg, 67(5), pp.35~43 (2009)
  33. Dodson TB, "Intravenous bisphosphonate therapy and bisphosphonate- related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5), pp.44~52 (2009)

관련 논문AI추천

경구 bisphosphonate를 복용하는 환자에서 발생한 bisphosphonate-related osteonecrosis of jaw에 대한 임상적 특징 및 처치: 증례보고윤현중, 이상화, 최우성대한구강악안면외과학회 · 대한구강악안면외과학회지2010 · 제36권 제6호비스포스포네이트 관련 악골 골괴사: 문헌고찰김수관, 김은식, 김지원, 김철만, 오지수, 유재식, 임경섭치의학연구원 · Oral Biology Research2014 · 제38권 제1호비스포스포네이트로 인한 하악 및 상악골에 발생한 골괴사에 대한 임상적 연구김태완, 송승일, 이정근, 정혜린대한구강악안면외과학회 · 대한구강악안면외과학회지2009 · 제35권 제5호Bisphosphonates induced osteonecrosis of the jaw의 기전, 예방, 위험 평가 및 치료 방법김종관, 김창성, 박정철, 정의원, 조규성, 채중규, 최성호대한치주과학회 · Journal of Periodontal & Implant Science2009 · 제39권 제1호골다공증 치료 약제와 턱뼈괴사증의 이해김선종, 김진우대한치과의사협회 · 대한치과의사협회지2021 · 제59권 제11호MRONJ 예방과 치료를 위한 최신지견김선종, 박정현대한치과의사협회 · 대한치과의사협회지2016 · 제54권 제4호

이 간행물의 다른 논문 (11건)

토끼의 하악골에서 β-TCP와 rhBMP-2의 골형성 효과에 대한 형태계측학적 연구양정은, 사시카라 바라라만, 김규남, 왕붕, 김일규, 장재원pp. 161-171Epithelial-mesenchymal transition in osteogenic sarcoma of the neck following oral squamous cell carcinoma육종인, 김남희, 김형준, 박원서, 차인호, 한선희, 서동준, 김현실pp. 172-176항-표피성장인자수용체 단클론항체와 DNA 토포이소머라제 억제제에 의한 마우스 모델에서의 타액선 선낭암종 성장 억제박영욱, 이희수pp. 177-185미성숙 매복지치의 치낭, 치수, 치근유두 조직에서 다능성 줄기세포의 분리와 특성화에 대한 연구김욱규, 신상훈, 강은주, 김종렬, 변준호, 박봉욱, 노규진, 송정호pp. 186-196Nasotracheal intubation시 비강 내 외상을 줄이기 위한 술전 computed tomography를 이용한 평가 및 전처지강현, 최영준, 김경수, 김한림, 윤경인pp. 197-201
원문 보기